Mizuho Boosts Cabot (NYSE:CBT) Price Target to $122.00

Cabot (NYSE:CBT) had its price objective increased by Mizuho from $103.00 to $122.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The firm currently has an outperform rating on the specialty chemicals company’s stock.

Other equities analysts have also issued reports about the stock. UBS Group cut their price target on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. JPMorgan Chase & Co. increased their price target on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $105.00.

Cabot Trading Down 2.6 %

CBT traded down $3.06 during trading on Tuesday, hitting $113.54. 41,352 shares of the stock were exchanged, compared to its average volume of 339,305. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot has a 1 year low of $70.63 and a 1 year high of $117.46. The firm has a 50 day simple moving average of $108.94 and a 200 day simple moving average of $101.34. The firm has a market cap of $6.22 billion, a price-to-earnings ratio of 17.30, a P/E/G ratio of 0.92 and a beta of 1.20.

Cabot (NYSE:CBT) last announced its earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). Cabot had a return on equity of 27.14% and a net margin of 9.51%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter in the prior year, the firm posted $1.65 earnings per share. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, equities analysts expect that Cabot will post 7.82 EPS for the current year.

Insider Buying and Selling at Cabot

In related news, EVP Jeff Ji Zhu sold 1,201 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now owns 96,000 shares in the company, valued at $10,194,240. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the transaction, the executive vice president now owns 96,000 shares in the company, valued at approximately $10,194,240. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of the company’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the sale, the executive vice president now owns 61,688 shares of the company’s stock, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,665 shares of company stock valued at $4,986,299 over the last ninety days. Corporate insiders own 3.07% of the company’s stock.

Hedge Funds Weigh In On Cabot

Several institutional investors and hedge funds have recently bought and sold shares of CBT. Wolff Wiese Magana LLC acquired a new position in shares of Cabot in the 3rd quarter worth approximately $25,000. UMB Bank n.a. increased its stake in Cabot by 53.9% in the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company’s stock valued at $41,000 after purchasing an additional 130 shares during the last quarter. CWM LLC raised its holdings in Cabot by 60.6% during the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 157 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in shares of Cabot by 197.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company’s stock valued at $47,000 after buying an additional 277 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Cabot by 33.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock valued at $48,000 after buying an additional 119 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.